Form 4 Tracker
Viking Therapeutics, Inc.
VKTX

7 insider filings · Latest: Aug 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 6, 2025Jan 6 10:16 PMBRIAN LIAN
Proposed Sale
194,490$42.75$8.3M

View →

Nov 8, 2024Nov 8 11:13 PMLAWSON MACARTNEY
Proposed Sale
2,000$68.67$137.3K

View →

Oct 28, 2024Oct 28 8:37 PMGREG ZANTE
Proposed Sale
131,687$78.03$10.3M

View →

Oct 25, 2024Oct 25 8:10 PMRouan Sarah Kathryn
Proposed Sale
11,000$80.86$889.4K

View →

Oct 25, 2024Oct 25 8:01 PMSINGLETON J MATTHEW
Proposed Sale
16,000$79.47$1.3M

View →

Sep 20, 2024Sep 20 8:29 PMLian Brian
Proposed Sale
216,130$18.41$4.0M

View →

Sep 20, 2024Sep 20 8:13 PMSINGLETON J MATTHEW
Proposed Sale
10,300$69.50$715.9K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 1, 2026Aug 7 8:34 PMDorothy Elizabeth Kelly-GemmellDirector
Grant/Award
40,800$31.7440,800(D)

View →

Jun 1, 2026Jun 3 11:44 PMHubert C ChenChief Medical Officer
Grant/Award
190,000$31.27190,000(D)

View →

Jan 12, 2026Jan 27 12:57 AMNeil William AubuchonChief Commercial Officer
Grant/Award
180,000$31.76180,000(D)

View →